PMV Pharmaceuticals, Inc.
PMVPNASDAQ
Healthcare
Biotechnology
$1.31
-0.03(-2.2%)
52W $0.84 – $1.80
Quick:
8-K
Mar 6, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Mar 6, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 9, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 12, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Nov 12, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 12, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Oct 27, 2025 (5 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13G
Sep 23, 2025 (6 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Sep 10, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Aug 13, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Aug 7, 2025 (8 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Aug 7, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 9, 2025 (10 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
May 15, 2025 (10 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
May 9, 2025 (11 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
May 9, 2025 (11 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Apr 8, 2025 (12 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
10-K
Mar 3, 2025 (1 years ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures